Limerick BioPharma aims to prevent organ rejection, treat cause of diabetes MedCity News The first of Limerick BioPharma's lead candidates, LIM-0705, is designed to improve the safety of existing immunosuppressive drugs used to prevent organ rejection in organ transplant patients. Immunosuppressive drugs are potent and effective, ... |
